JPH0610148B2 - Cycloalkyl alkynes - Google Patents

Cycloalkyl alkynes

Info

Publication number
JPH0610148B2
JPH0610148B2 JP4150084A JP15008492A JPH0610148B2 JP H0610148 B2 JPH0610148 B2 JP H0610148B2 JP 4150084 A JP4150084 A JP 4150084A JP 15008492 A JP15008492 A JP 15008492A JP H0610148 B2 JPH0610148 B2 JP H0610148B2
Authority
JP
Japan
Prior art keywords
solution
hydroxy
mixture
minutes
lithium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4150084A
Other languages
Japanese (ja)
Other versions
JPH05194292A (en
Inventor
テオドール・ルカク
ミラン・ソウクプ
エーリツヒ・ビドマー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPH05194292A publication Critical patent/JPH05194292A/en
Publication of JPH0610148B2 publication Critical patent/JPH0610148B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/10Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by etherified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/60Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by elimination of -OH groups, e.g. by dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/05Alcohols containing rings other than six-membered aromatic rings
    • C07C33/14Alcohols containing rings other than six-membered aromatic rings containing six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/02Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
    • C07C35/08Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings
    • C07C35/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings with unsaturation at least in the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/14Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/14Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
    • C07C403/16Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms not being part of —CHO groups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12CBEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C11/00Fermentation processes for beer
    • C12C11/02Pitching yeast
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】本発明はカロチノイド合成における中間体
として有用なシクロアルキルアルキン類に関する。
The present invention relates to cycloalkylalkynes useful as intermediates in carotenoid synthesis.

【0002】本発明によって提供されるシクロアルキル
アルキン類は一般式
Cycloalkylalkynes provided by the present invention have the general formula

【0003】[0003]

【化2】 [Chemical 2]

【0004】式中、R2は水素またはヒドロキシを表わ
し、R3はヒドロキシまたは=CH−CH2−OHを表わ
し、R4は−CO−OR6′または−CO−R6″を表わ
し、R6′はアルキルを表わし、そしてR6″はアリール
またはアルキルアリールを表わす、で示される化合物で
ある。
In the formula, R 2 represents hydrogen or hydroxy, R 3 represents hydroxy or ═CH—CH 2 —OH, R 4 represents —CO—OR 6 ′ or —CO—R 6 ″, and R 6 'represents an alkyl, and R 6 "represents an aryl or alkyl aryl, in which a compound represented.

【0005】本発明によれば、上記式Iの化合物は、R
4OHの開裂(cleavage)によって一般式
According to the invention, the compounds of formula I above are R
General formula by cleavage of 4 OH

【0006】[0006]

【化3】 [Chemical 3]

【0007】式中、R2及びR3は上記の意味を有する、
で示される化合物に転化することができる。
Wherein R 2 and R 3 have the meanings given above,
Can be converted to a compound represented by

【0008】「アルキル」、「アリール」及び「アルキ
ルアリール」なる語には、好ましくは炭素原子10個ま
でを含むアルキル、アリール及びアルキルアリール基が
包含される。これらの基の例はメチル、エチル、フェニ
ル、トリル等である。
The terms "alkyl", "aryl" and "alkylaryl" include alkyl, aryl and alkylaryl groups preferably containing up to 10 carbon atoms. Examples of these groups are methyl, ethyl, phenyl, tolyl and the like.

【0009】本発明にした違えば、式Iの化合物を比較
的温和な条件下で且つ良好な収率において式IIの純粋な
化合物に転化し得ることが見出された。
According to the invention, it has been found that the compounds of the formula I can be converted into the pure compounds of the formula II under relatively mild conditions and in good yields.

【0010】式IIの化合物の本発明による製造はそれ自
体既知の方法において、加熱によりそして/または触媒
の存在下において、式Iの化合物におけるR4OHを開
裂させることによって行うことができる。適当な触媒は
例えば次のものである:a)(例えばイミダゾール、
1,2,4−トリアゾール、アニリン)、b)強酸(好
ましくはpKa<1の酸)と有機窒素塩基との塩、特に
クロライド、ブロマイド及びトシレート(例えばピリジ
ニウムp−トシレート)、c)ホスホニウム塩(例えば
トリフェニルホスホニウムクロライドまたはブロマイ
ド)、d)酸、好ましくはpKa<1の強酸〔例えばト
ルエンスルホン酸、アンバーリスト(Amberlys
t)A 15R(Fluka AG)、塩化水素酸、硫
酸〕、e)トリアルキルクロロシラン(例えばトリメチ
ルクロロシラン)、f)リチウム塩、例えば強(pKa
<1)酸のリチウム塩(例えば塩化リチウム、過塩素酸
リチウム、四フツ化ホウ素酸リチウム)、並びにg)パ
ラジウム−(O)触媒(例えば酢酸パラジウムの付加に
よる)。
The preparation of the compounds of the formula II according to the invention can be carried out in a manner known per se by cleaving the R 4 OH in the compounds of the formula I by heating and / or in the presence of a catalyst. Suitable catalysts are, for example: a) (eg imidazole,
1,2,4-triazole, aniline), b) salts of strong acids (preferably acids with pKa <1) with organic nitrogen bases, especially chlorides, bromides and tosylates (eg pyridinium p-tosylate), c) phosphonium salts ( For example triphenylphosphonium chloride or bromide), d) acids, preferably strong acids with pKa <1 [eg toluenesulfonic acid, Amberlys.
t) A 15 R (Fluka AG), hydrochloric acid, sulfuric acid], e) trialkylchlorosilane (eg trimethylchlorosilane), f) lithium salt, eg strong (pKa)
<1) Lithium salt of acid (for example, lithium chloride, lithium perchlorate, lithium tetrafluoroborate), and g) Palladium- (O) catalyst (for example, by addition of palladium acetate).

【0011】反応温度は殊にR4の意味及び反応を触媒
の存在下または不存在下で行うかに依存する。要求され
る反応温度は一般に200℃以下である;しかしなが
ら、或る場合には、R4OHの開裂は室温でも起こる。
圧力は臨界的ではない。従ってこの反応は好ましくは大
気圧下で行う。
The reaction temperature depends in particular on the meaning of R 4 and whether the reaction is carried out in the presence or in the absence of a catalyst. The required reaction temperature is generally below 200 ° C .; however, in some cases the cleavage of R 4 OH also occurs at room temperature.
Pressure is not critical. Therefore, this reaction is preferably carried out at atmospheric pressure.

【0012】本発明による式Iの化合物の式IIの化合物
への転化は、不活性有機溶媒、例えばエーテル、アルコ
ール、ニトリル、アミドまたは飽和した、芳香族もしく
は塩素化された炭化水素中で有利に行われる。好ましい
溶媒の例はジエチルエーテル、テトラヒドロフラン、エ
チレングリコールジメチルエーテル、ジエチレングリコ
ールジメチルエーテル、トリエチレングリコールジメチ
ルエーテル、メタノール、アセトニトリル、ジメチルホ
ルムアミド、ヘキサン、トルエン、ベンゼン、キシレ
ン、塩化メチレン、ジクロロエタン等である。
The conversion of compounds of the formula I into compounds of the formula II according to the invention is preferably carried out in inert organic solvents such as ethers, alcohols, nitriles, amides or saturated, aromatic or chlorinated hydrocarbons. Done. Examples of preferred solvents are diethyl ether, tetrahydrofuran, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, methanol, acetonitrile, dimethylformamide, hexane, toluene, benzene, xylene, methylene chloride, dichloroethane.

【0013】本発明によって提供される方法は触媒の存
在下においてまた不存在下において行うことができる。
本方法を触媒の存在下において行う場合、触媒を触媒量
またはそれ以上の量で用いることができる。好ましい触
媒は有機窒素塩基、これらの塩基の塩及びリチウム塩で
ある。
The process provided by the present invention can be carried out in the presence or absence of a catalyst.
If the process is carried out in the presence of a catalyst, the catalyst can be used in catalytic amounts or higher. Preferred catalysts are organic nitrogen bases, salts of these bases and lithium salts.

【0014】本発明によって提供される方法の更に好ま
しい態様は、R3が基=CH−CH2OHを表わす式Iの
化合物をホスホニウム塩、好ましくはトリフェニルホス
ホニウムクロライドまたはブロマイドの等モル量または
これ以上の量の存在下において反応させることからな
る。この態様に従えば、まず対応する式IIの化合物が生
成せしめられ、次いでこのものが対応するホスホニウム
塩に直接転化される〔即ち、R3におけるヒドロキシ基
がホスホニウム塩、例えば−P(C65)3 +Cl-または
−P(C65)3 +Br-に転化される〕。
A further preferred embodiment of the process provided by the present invention is that the compound of formula I in which R 3 represents the group ═CH—CH 2 OH is a phosphonium salt, preferably an equimolar amount of triphenylphosphonium chloride or bromide or this It consists of reacting in the presence of the above amount. According to this embodiment, first the corresponding compound of formula II is formed, which is then directly converted to the corresponding phosphonium salt [ie the hydroxy group at R 3 is a phosphonium salt, for example -P (C 6 H 5) 3 + Cl - or -P (C 6 H 5) 3 + Br - is converted to].

【0015】本発明によって提供される方法に従えば、
2がヒドロキシを表わす式Iの化合物を使用することが
好ましい。
According to the method provided by the present invention,
Preference is given to using compounds of the formula I in which R 2 represents hydroxy.

【0016】R3によって表わされる基=CH−CH2
OH中に存在する二重結合はトランス立体配置を有する
ことが好ましい。
The group represented by R 3 = CH-CH 2-
The double bond present in OH preferably has the trans configuration.

【0017】上記式IにおいてR4で表わされる特に好ま
しい基は基−CO−CR6′であり、特にR6′がC1
6−アルキルを表わす基である。殊に好ましい基は−
CO−OCH3及び−CO−OC25である。上記式Iに
おいてR4が基−CO−R6″を表わす場合、それは殊に
R″がアリールであるような基(例えばベンゾイル)で
ある。
A particularly preferred group for R 4 in formula I above is the group —CO—CR 6 ′, especially where R 6 ′ is C 1- .
A group representing C 6 -alkyl. A particularly preferred group is-
CO-OCH a 3 and -CO-OC 2 H 5. When R 4 in the above formula I represents the radical —CO—R 6 ″, it is in particular a radical in which R ″ is aryl (eg benzoyl).

【0018】原則的に、シクロヘキシル環の6−位にお
ける水素元素及び基R4O−が相互にシス位置[syn除
去(elimination)]を表わす式Iの化合物
が更に好ましい。
In principle, preference is also given to compounds of the formula I in which the elemental hydrogen at the 6-position of the cyclohexyl ring and the radical R 4 O-- represent one another in the cis position (syn elimination).

【0019】本発明によって提供される方法の更に好ま
しい態様は一般式
A further preferred embodiment of the method provided by the present invention is the general formula

【0020】[0020]

【化4】 [Chemical 4]

【0021】式中、R3及びR4は上記の意味を有する、
の化合物またはその光学的対掌体を立体的に障害された
塩基性リチウム化合物の存在下においてR4OHの開裂
によって一般式
Wherein R 3 and R 4 have the meanings given above,
Of the compound of formula (I) or its optical antipode by cleavage of R 4 OH in the presence of a sterically hindered basic lithium compound to give a compound of the general formula

【0022】[0022]

【化5】 [Chemical 5]

【0023】式中、R3は上記の意味を有する、の化合
物またはその光学的対掌体に転化することからなる。
Wherein R 3 has the meanings given above and comprises conversion to the compound or its optical antipodes.

【0024】「立体的に障害された塩基性リチウム化合
物」なる語には、塩基性基上に立体障害を有し〔基−O
4に対する求核的攻撃(nucleophilic
attack)を避けるため〕且つ少なくとも9、好ま
しくは少なくとも11のpKa値をもつ有機化合物から
誘導されるリチウム−有機化合物が包含される。立体障
害は例えば1−位における炭素原子で枝分れまたは置換
によって、或いはベンゼン環のオルト位置における置換
によって行うことができる。かかる化合物の中で好まし
いものは上記の条件を満すアルキルリチウム、リチウム
アルカノレート、リチウムフェノレート、リチウムアル
キルアミド等、例えばリチウムtert.ブチレート、
リチウム1,1−ジメチルペンタノレート、リチウム
2,6−ジメチルフェノレート、リチウム2,6−ジ
(tert.ブチル)フェノレート、リチウム2,6−
ジクロロフェノレート、tert.ブチルリチウム、
2,6−ジ(tert.ブチル)フェニルリチウム及び
リチウムジイソプロピルアミドである。
The term "sterically hindered basic lithium compound" has a steric hindrance on a basic group [group -O].
Nucleophilic attack on R 4
In order to avoid attack) and lithium-organic compounds derived from organic compounds having a pKa value of at least 9, preferably at least 11. Steric hindrance can be effected, for example, by branching or substitution at the carbon atom in the 1-position or by substitution at the ortho position of the benzene ring. Among these compounds, preferred are alkyllithium, lithium alkanolate, lithium phenolate, lithium alkylamide, etc., which satisfy the above-mentioned conditions, such as lithium tert. Butyrate,
Lithium 1,1-dimethylpentanolate, lithium 2,6-dimethylphenolate, lithium 2,6-di (tert.butyl) phenolate, lithium 2,6-
Dichlorophenolate, tert. Butyl lithium,
2,6-di (tert.butyl) phenyllithium and lithium diisopropylamide.

【0025】この態様において、式Ia(またはその対
掌体)の化合物1モル当り好ましくは少なくとも約2モ
ルのリチウム化合物を用いる。特に好ましい具体化例に
おいては、リチウム化合物約2〜3モル当量を用いる
が、さらに多量に用いても反応に何ら有害な影響はな
い。
In this embodiment, preferably at least about 2 moles of lithium compound are used per mole of compound of Formula Ia (or its antipode). In a particularly preferred embodiment, about 2 to 3 molar equivalents of lithium compound are used, but larger amounts will not have any detrimental effect on the reaction.

【0026】式Iの化合物の反応に関連して上に述べた
温度、圧力及び溶媒は同様にこの態様にも適用されう
る。しかしながら、この態様は好ましくは約40℃〜約
70℃の温度で行われる。飽和炭化水素及び芳香族炭化
水素が特に好ましい溶媒である。
The temperatures, pressures and solvents mentioned above in connection with the reaction of the compounds of the formula I are likewise applicable to this embodiment. However, this embodiment is preferably performed at a temperature of about 40 ° C to about 70 ° C. Saturated hydrocarbons and aromatic hydrocarbons are particularly preferred solvents.

【0027】この態様は高収率を与える。更にR3が=
CH−CH2−OHを表わす場合のR3中に存在する二重
結合の立体配置は保持される。更に、一般に式Iの化合
物及びその光学的対掌体(但し残りの立体異性体ではな
い)のみが上記の温和な温度条件下で十分に反応するた
めに、この態様は純粋な異性体化合物を製造する際に特
に適当である。
This embodiment gives a high yield. Furthermore, R 3 =
Steric configuration of the double bonds present in R 3 when it represents a CH-CH 2 -OH is maintained. In addition, this embodiment provides pure isomer compounds because generally only the compounds of formula I and their optical antipodes (but not the remaining stereoisomers) react well under the mild temperature conditions described above. It is particularly suitable for manufacturing.

【0028】上記式IaにおけるR3は好ましくは基=
CH−CH2−OHを表わす。この基における二重結合
は好ましくはトランス立体配置で存在する。R4によっ
て表わされる好ましい基は−CO−OCH3、−CO−
OC25及び−CO−C65である。
R 3 in the above formula Ia is preferably a group =
It represents a CH-CH 2 -OH. The double bond in this group is preferably present in the trans configuration. Preferred groups represented by R 4 is -CO-OCH 3, -CO-
It is OC 2 H 5, and -CO-C 6 H 5.

【0029】式Iの化合物は新規なものであり、そして
また本発明の一部を構成するものである。この化合物は
それ自体既知の方法において、例えば対応するリチウム
アルコレート(R4がリチウムを表わす式Iの化合物)
から、対応するクロライド、即ち式Cl−CO−C
6′またはCl−CO−CR6″〔ここで、R6′及び
6″は上記の意味を有する〕の化合物との反応によっ
て製造することができる。この反応に対して必要なリチ
ウムアルコレートはそれ自体既知の方法において、対応
するシクロヘキサノンを対応するアルキニルリチウムと
反応させることにより得ることができる。この場合に更
に存在するヒドロキシ基(R3中)は有利には保護され
た形態で存在する。これらの保護基は必要に応じて、基
4の導入前または後に離脱させることができる。
The compounds of formula I are new and also form part of the invention. This compound is prepared in a manner known per se, for example in the corresponding lithium alcoholate (compound of formula I in which R 4 represents lithium).
From the corresponding chloride, namely the formula Cl-CO-C
R 6 'or Cl-CO-CR 6 "[wherein, R 6' and R 6" have the meaning given above] can be prepared by reaction of a compound of. The lithium alcoholate required for this reaction can be obtained by reacting the corresponding cyclohexanone with the corresponding alkynyl lithium in a manner known per se. The hydroxy groups (in R 3 ) which are additionally present in this case are preferably present in protected form. These protecting groups can optionally be eliminated before or after the introduction of the radical R 4 .

【0030】式IIの化合物のカロチノイドへの転化は公
知の方法或いはそれ自体既知の方法において、例えば滝
と得なアルデヒドまたはホスホニウム塩に転化し、次い
でビッテイヒ(Wittig)反応に付すことによって
行うことができる。
The conversion of the compound of formula II into carotenoids can be carried out in a known manner or in a manner known per se, for example by conversion into a water-soluble aldehyde or phosphonium salt, which is then subjected to a Wittig reaction. it can.

【0031】本発明を以下の実施例によつて更に詳細に
説明する。
The present invention will be described in more detail with reference to the following examples.

【0032】[0032]

【実施例】実施例1 エチル(1S,4R,6R)−4−ヒドロキシ−1−(3
−ヒドロキシ−1−ブチニル)−2,2,6−トリメチル
シクロヘキシルカルボネート10.14gを熱ジメチル
ホルムアミド50mlに溶解した。この溶液をピリジニ
ウムp−トシレート1gで処理し、この混合物を予熱し
た油浴中で1.5時間撹拌した(油浴温度90〜93
℃、内部温度約79〜82℃)。次に混合物を半飽和塩
化ナトリウム溶液500mlに注ぎ、ジエチルエーテル
各200mlで3回抽出した。有機相を飽和塩化ナトリ
ウム溶液で1回洗浄し、硫酸ナトリウム上で乾燥し、そ
して蒸発させた。得られた粗製の生成物(8.3g)を
シリカゲル上でヘキサン/ジエチルエーテル(容量比
1:1)によつてクロマトグラフイーにかけた。かくし
て、(4R)−4−(4−ヒドロキシ−2,2,6−トリ
メチル−1−シクロヘキセニル)−3−ブチン−2−オ
ール5.9g(83.3%)が得られた。
EXAMPLES Example 1 Ethyl (1S, 4R, 6R) -4-hydroxy-1- (3
10.14 g of -hydroxy-1-butynyl) -2,2,6-trimethylcyclohexyl carbonate were dissolved in 50 ml of hot dimethylformamide. This solution was treated with 1 g of pyridinium p-tosylate and the mixture was stirred in a preheated oil bath for 1.5 hours (oil bath temperature 90-93.
C, internal temperature about 79-82C). The mixture was then poured into 500 ml of semisaturated sodium chloride solution and extracted 3 times with 200 ml of diethyl ether each time. The organic phase was washed once with saturated sodium chloride solution, dried over sodium sulphate and evaporated. The crude product obtained (8.3 g) was chromatographed on silica gel with hexane / diethyl ether (volume ratio 1: 1). Thus, 5.9 g (83.3%) of (4R) -4- (4-hydroxy-2,2,6-trimethyl-1-cyclohexenyl) -3-butyn-2-ol was obtained.

【0033】出発物質として用いたエチル(1S,4R,
6R)−4−ヒドロキシ−1−(3−ヒドロキシ−1−
ブチニル)−2,2,6−トリメチルシクロヘキシルカル
ボネートは次の如くして製造した; a)磁気撹拌機、温度計、滴下ロート及び不活性ガス化
装置を備えた四つ口フラスコ中で、(4R,6R)−4
−ヒドロキシ−2,2,6−トリメチルシクロヘキサノン
19.52gで無水テトラヒドロフラン40ml及びピ
リジニウムp−トシレート20mgの混合物にアルゴン
下で溶解し、次にこの溶液に15〜20℃で約20分以
内にイソプロピルメチルエーテル14.4gを滴下し
た。得られた溶液Aを節c)に述べた如くして処理し
た。
Ethyl used as starting material (1S, 4R,
6R) -4-hydroxy-1- (3-hydroxy-1-
Butynyl) -2,2,6-trimethylcyclohexyl carbonate was prepared as follows: a) In a four-necked flask equipped with a magnetic stirrer, thermometer, dropping funnel and inert gasifier, 4R, 6R) -4
-Hydroxy-2,2,6-trimethylcyclohexanone was dissolved in a mixture of 40 ml anhydrous tetrahydrofuran and 20 mg pyridinium p-tosylate with 19.52 g under argon and then added to this solution at 15-20 ° C within about 20 min. 14.4 g of ether was added dropwise. The resulting solution A was processed as described in section c).

【0034】b)撹拌機、温度計、滴下ロート上昇管及
び不活性ガス化装置を備えたスルホン化用フラスコ中に
無水テトラヒドロフラン80ml中の3−ブチン−2−
イルトリメチルシリルエーテル23.5gの溶液をアル
ゴン下で入れ、−30℃に冷却し、−30℃〜20℃で
10分以内に、ヘキサン中のブチルリチウムの約1.5
6M溶液105mlで滴下処理した。この混合物を−1
0℃で更に30分間撹拌し、次に再び−40℃に冷却し
た。得られた溶液Bを節c)に述べた如くして処理し
た。
B) 3-butyne-2- in 80 ml of anhydrous tetrahydrofuran in a sulfonation flask equipped with stirrer, thermometer, dropping funnel riser and inert gasifier.
A solution of 23.5 g of yltrimethylsilyl ether was charged under argon, cooled to -30 ° C, and within 10 minutes at -30 ° C to 20 ° C, about 1.5 butyllithium in hexane.
The solution was added dropwise with 105 ml of a 6M solution. -1 for this mixture
Stir at 0 ° C. for a further 30 minutes and then cool again to −40 ° C. The resulting solution B was processed as described in section c).

【0035】c)溶液Aを−40℃で10分以内に溶液
Bに滴下した。この混合物を更に30分間撹拌し、次に
クロロギ酸エチル15.7mlで処理し、混合物を撹拌
しながら1時間以内に室温に加温した。次に混合物を0
℃に冷却し、撹拌しながら3N硫酸100mlで処理
し、0〜5℃で更に30分間撹拌した。この混合物を酢
酸エチル250mlで希釈し、水相を分離した。水相を
酢酸エチル各250mlで2回逆抽出した。有機相を飽
和炭酸水素ナトリウム溶液各250mlで3回、そして
飽和塩化ナトリウム溶液で250mlで1回洗浄し、合
液し、硫酸ナトリウム上で乾燥した。乾燥剤を濾別し、
濾液を回転蒸発機で濃縮(水浴温度50℃)した後、粗
製の生成物43.6gが得られ、このものをシリカゲル
上でヘキサン/ジエチルエーテル(容量比1:1)によ
つてクロマトグラフイーにかけた。生成物を含むフラク
シヨンから、やや帯黄色の油として合計36.5g(9
7.8%)のエチル(1S,4R,6R)−4−ヒドロキ
シ−1−(3−ヒドロキシ−1−ブチニル)−2,2,6
−トリメチルシクロヘキシルカルボネートが得られた。 実施例2 磁気撹拌機、温度計、還流冷却器及びアルゴンヘツドピ
ース(headpiece)を備えた二口フラスコ中で、イミダ
ゾール6.7gをアルゴン下でトリエチレングリコール
ジメチルエーテル40mlに溶解し、この溶液を油浴中
で195℃に加熱した。次にトリエチレングリコールジ
メチルエーテル15ml中のエチル(1S,4R,6R)
−4−ヒドロキシ−1−(5−ヒドロキシ−3−メチル
−3E−ペンテン−1−イニル)−2,2,6−トリメチ
ルシクロヘキシルカルボネート8.0gの溶液を内部温
度188〜190℃で60分以内に滴下した。この混合
物を同一温度に更に30分間保存し、次に氷/水200
mlに注いだ。水相をジエチルエーテル各250mlで
2回抽出した。合液したエーテル相を水各100mlで
4回洗浄し、硫酸ナトリウム上で乾燥し、約50℃で回
転蒸発機にて濃縮し、次に高真空下にて室温で3時間乾
燥した。得られた粗製の生成物(0.6g)をシリカゲ
ル上でジエチルエーテル/ヘキサン(容量比1:1)に
よつてクロマトグラフイーにかけ、かくしてやや帯黄色
の油として、(4R)−5−(4−ヒドロキシ−2,2,
6−トリメチル−1−シクロヘキセニル)−3−メチル
−2−ペンテン−4−イン−1−オール3.5g(61.
4%)を単離することができた(比2E/2Z=91.
0:4.7)。
C) Solution A was dissolved at -40 ° C within 10 minutes.
It was dripped at B. The mixture is stirred for a further 30 minutes, then
Treat with 15.7 ml of ethyl chloroformate and stir the mixture
While warming to room temperature within 1 hour. Then mix 0
Cool to ℃ and treat with 100 ml of 3N sulfuric acid with stirring.
And stirred at 0-5 ° C for an additional 30 minutes. Vinegar this mixture
It was diluted with 250 ml of ethyl acidate and the aqueous phase was separated. The water phase
It was back-extracted twice with 250 ml each of ethyl acetate. Tired of the organic phase
250 ml of sodium bicarbonate solution three times, and
Wash once with 250 ml of saturated sodium chloride solution,
Dried and dried over sodium sulfate. The desiccant is filtered off,
After concentrating the filtrate on a rotary evaporator (water bath temperature 50 ° C.), the crude
43.6 g of the product of
With hexane / diethyl ether (volume ratio 1: 1) above
Then, it was chromatographed. Fracture containing product
From Chillon, a total of 36.5 g (9
7.8%) ethyl (1S, 4R, 6R) -4-hydroxy
Ci-1- (3-hydroxy-1-butynyl) -2,2,6
-Trimethylcyclohexyl carbonate was obtained. Example 2 Magnetic stirrer, thermometer, reflux condenser and argon head pipe
In a two-necked flask equipped with a headpiece, imida
6.7 g of sol was added to triethylene glycol under argon.
Dissolve in 40 ml of dimethyl ether and add this solution in an oil bath
Heated to 195 ° C. Then triethylene glycol di
Ethyl in 15 ml of methyl ether (1S, 4R, 6R)
-4-hydroxy-1- (5-hydroxy-3-methyl
-3E-Pentene-1-ynyl) -2,2,6-trimethyl
The solution of 8.0 g of rucyclohexyl carbonate was heated to the internal temperature.
Dropwise at 188-190 ° C within 60 minutes. This mix
Store the same at the same temperature for another 30 minutes, then ice / water 200
poured into ml. Aqueous phase with 250 ml of diethyl ether each
Extracted twice. Combined ether phases with 100 ml of water each
Wash 4 times, dry over sodium sulfate, and spin at about 50 ° C.
Concentrate on inversion evaporator and then dry under high vacuum at room temperature for 3 hours.
Dried The crude product obtained (0.6 g) was treated with silica gel.
On diethyl ether / hexane (volume ratio 1: 1)
Chromatography, and thus a little yellowish
Oil of (4R) -5- (4-hydroxy-2,2,
6-trimethyl-1-cyclohexenyl) -3-methyl
-2-Penten-4-yn-1-ol 3.5 g (61.
4%) could be isolated (ratio 2E / 2Z = 91.
0: 4.7).

【0036】出発物質として用いたエチル(1S,4R,
6R)−4−ヒドロキシ−1−(5−ヒドロキシ−3−
メチル−3E−ペンテン−1−イニル)−2,2,6−ト
リメチルシクロヘキシルカルボネートは次の如くして製
造した: a)磁気撹拌機、温度計、滴下ロート及び不活性ガス化
装置を備えた四つ口フラスコ中で、(4R,6R)−4
−ヒドロキシ−2,2,6−トリメチルシクロヘキサノン
52.0gをアルゴン下でテトラヒドロフラン65ml
及びピリジニウムp−トシレート50mgに溶解し、こ
の溶液を15〜20℃で20分以内にイソプロペニルメ
チルエーテル48.0gで滴下処理した。得られた帯黄
色の溶液Aを節c)に述べた如くして直接処理した。
Ethyl used as a starting material (1S, 4R,
6R) -4-hydroxy-1- (5-hydroxy-3-
Methyl-3E-penten-1-ynyl) -2,2,6-trimethylcyclohexyl carbonate was prepared as follows: a) equipped with magnetic stirrer, thermometer, dropping funnel and inert gasifier. In a four-necked flask, (4R, 6R) -4
-Hydroxy-2,2,6-trimethylcyclohexanone 52.0 g of tetrahydrofuran under argon 65 ml
And 50 mg of pyridinium p-tosylate, and the solution was treated dropwise with isopropenyl methyl ether 48.0 g within 20 minutes at 15 to 20 ° C. The resulting yellowish solution A was directly processed as described in section c).

【0037】b)撹拌機、温度計、滴下ロート上昇管及
び不活性ガス化装置を備えたスルホン化用フラスコ中
に、無水テトラヒドロフラン50ml中の5−(2−メ
トキシ−2−プロピル)オキシ−3−メチル−3E−ペ
ンテン−1−イン79gの溶液をアルゴン下で入れ、そ
して−20℃に冷却した。この溶液を−30℃〜20℃
で20分以内にヘキサン中のブチルリチウムの約1.5
6M溶液280mlで滴下処理し、生じた混合物を更に
30分間撹拌した。得られた橙色溶液Bを節c)に述べ
た如くして直接処理した。
B) 5- (2-methoxy-2-propyl) oxy-3 in 50 ml of anhydrous tetrahydrofuran in a sulfonation flask equipped with stirrer, thermometer, dropping funnel riser and inert gasifier. A solution of 79 g of -methyl-3E-penten-1-yne was charged under argon and cooled to -20 ° C. This solution is -30 ℃ ~ 20 ℃
Butyllithium in hexane about 1.5 in less than 20 minutes
It was treated dropwise with 280 ml of a 6M solution and the resulting mixture was stirred for a further 30 minutes. The resulting orange solution B was directly processed as described in section c).

【0038】c)溶液Bを−15℃で20分以内に溶液
Aで滴下処理し、この混合物を室温で更に30分間撹拌
した。混合物を−20℃に冷却し、撹拌しながらクロロ
ギ酸エチル42mlで処理し、次に得られた混合物を1
時間にわたつて室温に加温した。次に混合物をジエチル
エーテル250mlで希釈し、水相をジエチルエーテル
250mlで逆洗浄した。有機相を飽和塩化ナトリウム
溶液各250mlで2回洗浄し、合液し、硫酸ナトリウ
ム上で乾燥した。乾燥剤を濾別し、濾液を回転蒸発機で
濃縮(水浴温度50℃)した後、褐−黄色油として粗製
のエチル(1S,4R,6R)−4−(2−メトキシ−2
−プロピル)オキシ−1−[5−(2−メトキシ−2−
プロピル)オキシ−3−メチル−3E−ペンテン−1−
イニル]−2,2,6−トリメチルシクロヘキシルカルボ
ネート181.5gが得られた。
C) Solution B was treated dropwise with Solution A within 20 minutes at -15 ° C. and the mixture was stirred at room temperature for a further 30 minutes. The mixture is cooled to −20 ° C. and treated with 42 ml of ethyl chloroformate with stirring, then the mixture obtained is 1
Warm to room temperature over time. Then the mixture was diluted with 250 ml of diethyl ether and the aqueous phase was back-washed with 250 ml of diethyl ether. The organic phase was washed twice with 250 ml each of saturated sodium chloride solution, combined and dried over sodium sulphate. After filtering off the desiccant and concentrating the filtrate on a rotary evaporator (water bath temperature 50 ° C.), crude ethyl (1S, 4R, 6R) -4- (2-methoxy-2) was obtained as a brown-yellow oil.
-Propyl) oxy-1- [5- (2-methoxy-2-
Propyl) oxy-3-methyl-3E-pentene-1-
181.5 g of inyl] -2,2,6-trimethylcyclohexyl carbonate were obtained.

【0039】d)得られた褐−黄色油をテトラヒドロフ
ラン450ml及び水50mlに溶解し(濁つた溶
液)、ピリジニウムp−トシレート2gで処理し、更に
20分間撹拌した(透明な溶液)。次にこの褐−黄色油
溶液を固体の炭酸カリウム2gで処理し、回転蒸発機で
一定重量になるまで蒸発させた(浴温50℃)。残渣を
ジエチルエーテル250mlで希釈し、水250mlで
抽出した。水相を分離し、ジエチルエーテル250ml
で逆抽出した。有機相を飽和塩化ナトリウム溶液各25
0mlで2回洗浄し、合液し、そして硫酸ナトリウム上
で乾燥した。乾燥剤を濾別し、濾液を回転蒸発機で濃縮
(水浴温度50℃)した後、粗製の生成物140gが得
られ、このものをシリカゲル上でジエチルエーテル/ヘ
キサン(容量比1:1)によつてクロマトグラフイーに
かけた。生成物を含むフラクシヨンから、やや帯黄色油
として純粋なエチル(1S,4R,6R)−4−ヒドロキ
シ−1−(5−ヒドロキシ−3−メチル−3E−ペンテ
ン−1−イニル)−2,2,6−トリメチルシクロヘキシ
ルカルボネート合計99.0g(91.6%)が得られ
た。
D) The brown-yellow oil obtained was dissolved in 450 ml of tetrahydrofuran and 50 ml of water (turbid solution), treated with 2 g of pyridinium p-tosylate and stirred for a further 20 minutes (clear solution). The brown-yellow oil solution was then treated with 2 g of solid potassium carbonate and evaporated on a rotary evaporator to constant weight (bath temperature 50 ° C.). The residue was diluted with 250 ml of diethyl ether and extracted with 250 ml of water. The aqueous phase is separated and 250 ml of diethyl ether
Back-extracted with. 25 organic phase saturated sodium chloride solutions each
It was washed twice with 0 ml, combined and dried over sodium sulfate. After filtering off the drying agent and concentrating the filtrate on a rotary evaporator (water bath temperature 50 ° C.), 140 g of crude product are obtained, which is taken up on silica gel in diethyl ether / hexane (volume ratio 1: 1). I went to chromatography. From the product-containing fraction, pure ethyl (1S, 4R, 6R) -4-hydroxy-1- (5-hydroxy-3-methyl-3E-penten-1-ynyl) -2,2 as a slightly yellowish oil was obtained. A total of 99.0 g (91.6%) of 6,6-trimethylcyclohexyl carbonate was obtained.

【0040】実施例3 磁気撹拌機、還流冷却器及びアルゴンヘツドピースを備
えた二口フラスコ中で、イミダゾール4.4gをトリエ
チレングリコールジエチルエーテル50mlにアルゴン
下で溶解し、この溶液を油浴中で195℃に加熱した。
次にトリエチレングリコールジメチルエーテル10ml
中のエチル1−(5−ヒドロキシ−3−メチル−3E−
ペンテン−1−イニル)−2,2,6−トリメチルシクロ
ヘキシルカルボネート5gの溶液を内部温度185〜1
90℃で約20分以内に滴下した。この混合物を同一温
度に更に1時間保存し、次に氷/水200mlに注い
だ。水相をジエチルエーテル各250mlで2回抽出し
た。合液したエーテル相を水各100mlで4回洗浄
し、硫酸ナトリウム上で乾燥し、約40℃にて回転蒸発
器で濃縮し、次に高真空下にて室温で2時間乾燥した。
得られた粗製の生成物(3.6g)をシリカゲル上でジ
エチルエーテル/ヘキサン(容量比1:1)によつてク
ロマトグラフイーにかけた。生成物を含むフラクシヨン
から、やや帯黄色の油として5−(2,6,6−トリメチ
ル−1−シクロヘキセニル)−3−メチル−2−ペンテ
ン−4−イン−1−オール2.1g(59.5%)が得ら
れた。(比2E/2Z=98.8:0.6)。
Example 3 In a two-necked flask equipped with a magnetic stirrer, a reflux condenser and an argon headpiece, 4.4 g of imidazole was dissolved in 50 ml of triethylene glycol diethyl ether under argon and the solution was placed in an oil bath. Heated to 195 ° C.
Next, 10 ml of triethylene glycol dimethyl ether
1- (5-hydroxy-3-methyl-3E- in
A solution of 5 g of pentene-1-ynyl) -2,2,6-trimethylcyclohexyl carbonate was added at an internal temperature of 185-1.
It was added dropwise at 90 ° C. within about 20 minutes. The mixture was stored at the same temperature for a further 1 hour and then poured into 200 ml ice / water. The aqueous phase was extracted twice with 250 ml of diethyl ether each time. The combined ethereal phases were washed 4 times with 100 ml of water each time, dried over sodium sulphate, concentrated on a rotary evaporator at about 40 ° C. and then dried under high vacuum at room temperature for 2 hours.
The crude product obtained (3.6 g) was chromatographed on silica gel with diethyl ether / hexane (volume ratio 1: 1). From the product-containing fraction, 2.1 g (59%) of 5- (2,6,6-trimethyl-1-cyclohexenyl) -3-methyl-2-penten-4-yn-1-ol as a slightly yellowish oil was obtained. 0.5%) was obtained. (Ratio 2E / 2Z = 98.8: 0.6).

【0041】出発物質として用いたエチル1−(5−ヒ
ドロキシ−3−メチル−3E−ペンテン−1−イニル)
−2,2,6−トリメチルシクロヘキシルカルボネートは
次の如くして製造した: a)撹拌機、温度計、滴下ロート及びアルゴンヘツドピ
ースを備えたスルホン化用フラスコ中に、5−(2−メ
トキシ−2−プロピル)オキシ−3−メチル−3E−ペ
ンテン−1−イン115.1g及びテトラヒドロフラン
90mlを入れ、この混合物を−25℃に冷却し、この
温度で20分以内にヘキサン中のブチルリチウムの1.
6M溶液で滴下処理した。この混合物を0℃で更に15
分間撹拌し、次に−10℃に冷却し、この温度で15分
以内に2,2,6−トリメチルシクロヘキサノン72.9
gで滴下処理した。次に混合物を室温に加温し、更に2
時間撹拌した。この混合物を0℃に冷却し、この温度で
15分以内にクロロギ酸エチル67.5mlで滴下処理
し、放置して室温に加温し、そして更に1.5時間撹拌
した。次に混合物を飽和炭酸水素ナトリウム溶液1lに
注ぎ、ジエチルエーテル各1lで2回抽出した。有機相
を脱イオン水1lで洗浄し、硫酸ナトリウム上で乾燥
し、乾燥剤を濾別し、濾液を真空下にて回転蒸発機で濃
縮した(浴温度約45℃)。残渣から高真空下にて浴温
度60℃で1時間にわたり、5−(2−メトキシ−2−
プロピル)オキシ−3−メチル−3E−ペンテン−1−
インを除去した。粗製のエチル1−[5−(2−メトキ
シ−2−プロピル)オキシ−3−メチル−3E−ペンテ
ン−1−イニル]−2,2,6−トリメチルシクロヘキシ
ルカルボネート232.1g(117.3%)が得られ、
このものを更に精製せずに直接処理した。
Ethyl 1- (5-hydroxy-3-methyl-3E-penten-1-ynyl) used as starting material
-2,2,6-Trimethylcyclohexyl carbonate was prepared as follows: a) In a sulfonation flask equipped with stirrer, thermometer, dropping funnel and argon headpiece, 5- (2-methoxy) was used. 2-Propyl) oxy-3-methyl-3E-penten-1-yne 115.1 g and tetrahydrofuran 90 ml are charged, the mixture is cooled to -25 ° C. and butyl lithium in hexane at this temperature is added within 20 minutes. 1.
Dropwise treatment with 6M solution. This mixture is further stirred at 0 ° C for 15
Stir for minutes, then cool to -10 ° C and within 15 minutes at this temperature 2,2,6-trimethylcyclohexanone 72.9
Dropwise treatment with g. The mixture is then warmed to room temperature and further 2
Stir for hours. The mixture was cooled to 0 ° C., treated dropwise with 67.5 ml of ethyl chloroformate at this temperature within 15 minutes, allowed to warm to room temperature and stirred for a further 1.5 hours. Then the mixture was poured into 1 l of saturated sodium hydrogen carbonate solution and extracted twice with 1 l of diethyl ether each time. The organic phase was washed with 1 l of deionized water, dried over sodium sulphate, the desiccant was filtered off and the filtrate was concentrated under vacuum on a rotary evaporator (bath temperature approx. 45 ° C.). From the residue under high vacuum at a bath temperature of 60 ° C. for 1 hour, 5- (2-methoxy-2-
Propyl) oxy-3-methyl-3E-pentene-1-
The inn was removed. Crude ethyl 1- [5- (2-methoxy-2-propyl) oxy-3-methyl-3E-penten-1-ynyl] -2,2,6-trimethylcyclohexylcarbonate 232.1 g (117.3%) ) Is obtained,
This was directly processed without further purification.

【0042】b)上記節a)に述べた如くして得られた
粗製の生成物105.5gを、撹拌機、温度計及びアル
ゴン・ヘツドピースを備えたスルホン化用フラスコ中の
テトラヒドロフラン630mlに溶解し、この溶液を脱
イオン水105ml及びピリジニウムp−トシレート
5.25gで処理し、混合物を室温で更に30分間撹拌
した。この混合物を飽和炭酸水素ナトリウム溶液750
mlに注ぎ、ジエチルエーテル各600mlで3回抽出
した。有機相を半飽和炭酸水素ナトリウム溶液750m
lで洗浄し、硫酸ナトリウム上で乾燥し、乾燥剤を濾別
し、濾液を真空下にて回転蒸発機(浴温度約45℃)で
濃縮した。高真空下で乾燥した後、粗製の生成物84.
8g(116.9%)が得られ、このものをシリカゲル
上でヘキサン/ジエチルエーテル(容量比2:1)によ
つてクロマトグラフイーにかけた。かくして5−(2,
6,6−トリメチル−1−シクロヘキセニル)−3−メ
チル−2−ペンテン−4−イン−1−オール2.3g
(4.5%)及びエチル1−(5−ヒドロキシ−3−メ
チル−3E−ペンテン−1−イニル)−2,2,6−トリ
メチルシクロヘキシルカルボネート53.6g(73.9
%)が得られた。
B) 105.5 g of the crude product obtained as described in section a) above is dissolved in 630 ml of tetrahydrofuran in a sulfonation flask equipped with a stirrer, thermometer and argon headpiece. This solution was treated with 105 ml of deionized water and 5.25 g of pyridinium p-tosylate and the mixture was stirred at room temperature for a further 30 minutes. This mixture is added to a saturated sodium hydrogen carbonate solution 750
It was poured into 3 ml and extracted with 600 ml of diethyl ether three times. The organic phase is a semi-saturated sodium hydrogen carbonate solution 750 m.
Washed with l, dried over sodium sulphate, filtered off the drying agent and concentrated the filtrate under vacuum on a rotary evaporator (bath temperature approx. 45 ° C.). After drying under high vacuum, the crude product 84.
8 g (116.9%) were obtained, which was chromatographed on silica gel with hexane / diethyl ether (2: 1 by volume). Thus 5- (2,
2.3 g of 6,6-trimethyl-1-cyclohexenyl) -3-methyl-2-penten-4-yn-1-ol
(4.5%) and ethyl 1- (5-hydroxy-3-methyl-3E-penten-1-ynyl) -2,2,6-trimethylcyclohexyl carbonate 53.6 g (73.9).
%)was gotten.

【0043】実施例4 撹拌機、温度計、滴下ロート、還流冷却器及び不活性ガ
ス化装置を備えたスルホン化用フラスコ中にtert.
ブタノール16ml及び無水トルエン20mlをアルゴ
ン下で入れ、そして−25℃に冷却した。この溶液を−
30℃〜−20℃で10分以内にヘキサン中のブチルリ
チウムの1.56M溶液25mlで滴下処理し、この混
合物を冷却しながら更に30分間撹拌した。次にかくし
て製造したリチウムtert.ブチレートの溶液に約2
0℃で無水トルエン120ml中の(1S,4R,6R)
−4−ヒドロキシ−1−(5−ヒドロキシ−3−メチル
−3E−ペンテン−1−イニル)−2,2,6−トリメチ
ルシクロヘキシルベンゾエート14.4gの溶液を一度
に加えた。得られた懸濁液を油浴によつて注意して65
℃に加熱し、この温度で1.5時間撹拌した。その後、
混合物を氷/水150mlに注いだ。水相を分離し、ジ
エチルエーテル各150mlで2回抽出した。有機相を
飽和塩化ナトリウム溶液150mlで洗浄し、合液し、
そして硫酸ナトリウム上で乾燥し、約40℃にて回転蒸
発機で濃縮し、次に残渣を高真空下にて室温で1時間乾
燥した。得られた粗製の生成物(12.0g)をシリカ
ゲル上でジエチルエーテル/ヘキサン(容量比1:1)
によつてクロマトグラフイーにかけた。生成物を含むフ
ラクシヨンから、帯黄色の結晶として(4R)−5−
(4−ヒドロキシ−2,2,6−トリメチル−1−シクロ
ヘキセン−1−イル)−3−メチル−2E−ペンテン−
4−イン−1−オール合計7.5g(80%)が得られ
た(純度98.8%、2Z異性体含量1.1%)。
Example 4 In a sulfonation flask equipped with a stirrer, thermometer, dropping funnel, reflux condenser and inert gasifier, tert.
16 ml butanol and 20 ml anhydrous toluene were charged under argon and cooled to -25 ° C. This solution-
Within 10 minutes at 30 DEG C. to -20 DEG C., 25 ml of a 1.56 M solution of butyllithium in hexane were added dropwise and the mixture was stirred for a further 30 minutes while cooling. The lithium tert. About 2 in butyrate solution
(1S, 4R, 6R) in 120 ml of anhydrous toluene at 0 ° C
A solution of 14.4 g of -4-hydroxy-1- (5-hydroxy-3-methyl-3E-penten-1-ynyl) -2,2,6-trimethylcyclohexylbenzoate was added at once. Carefully transfer the resulting suspension to 65 with an oil bath.
Heat to ℃ and stir at this temperature for 1.5 hours. afterwards,
The mixture was poured into 150 ml ice / water. The aqueous phase was separated and extracted twice with 150 ml of diethyl ether each. The organic phase is washed with 150 ml of saturated sodium chloride solution, combined and
It was then dried over sodium sulphate and concentrated on a rotary evaporator at about 40 ° C., then the residue was dried under high vacuum at room temperature for 1 hour. The crude product obtained (12.0 g) was applied onto silica gel with diethyl ether / hexane (volume ratio 1: 1).
Then it was chromatographed. From the product-containing fraction, (4R) -5-as yellowish crystals.
(4-Hydroxy-2,2,6-trimethyl-1-cyclohexen-1-yl) -3-methyl-2E-pentene-
A total of 7.5 g (80%) of 4-in-1-ol was obtained (purity 98.8%, 2Z isomer content 1.1%).

【0044】出発物質として用いた(1S,4R,6R)
−4−ヒドロキシ−1−(5−ヒドロキシ−3−メチル
−3E−ペンテン−1−イニル)−2,2,6−トリメチ
ルシクロヘキシルベンゾエートは次の如くして製造し
た: a)テトラヒドロフラン20ml中の(4R,6R)−
4−ヒドロキシ−2,2,6−トリメチルシクロヘキサノ
ン16.4g及びピリジニウムp−トシレート30mg
の溶液をアルゴン下にて15〜20℃で10分以内にイ
ソプロペニルメチルエーテル16.0gで滴下処理し
た。
Used as starting material (1S, 4R, 6R)
-4-Hydroxy-1- (5-hydroxy-3-methyl-3E-penten-1-ynyl) -2,2,6-trimethylcyclohexylbenzoate was prepared as follows: a) () 4R, 6R)-
4-hydroxy-2,2,6-trimethylcyclohexanone 16.4 g and pyridinium p-tosylate 30 mg
Solution was treated dropwise with argon within 15 minutes at 15-20 ° C. with 16.0 g of isopropenyl methyl ether.

【0045】b)無水テトラヒドロフラン30ml中の
5−(2−メトキシ−2−プロピル)オキシ−3−メチ
ル−3E−ペンテン−1−イン27gの溶液をアルゴン
下で、−20℃に冷却し、次に−30℃〜20℃で10
分以内にヘキサン中のブチルリチウムの1.56M溶液
90mlで滴下処理し、この混合物を更に30分間撹拌
した。
B) A solution of 27 g of 5- (2-methoxy-2-propyl) oxy-3-methyl-3E-penten-1-yne in 30 ml of anhydrous tetrahydrofuran was cooled to -20 ° C under argon and then 10 at -30 ℃ to 20 ℃
Within minutes, it was treated dropwise with 90 ml of a 1.56 M solution of butyllithium in hexane and the mixture was stirred for a further 30 minutes.

【0046】c)上記節b)に述べた如くして得られた
溶液を−15℃で15分以内に、上記節a)に述べた如
くして製造した溶液で滴下処理し、この混合物を室温で
更に1時間撹拌した。混合物を−10℃に冷却し、撹拌
しながらベンゾイルクロライド18.6mlで処理し、
次に室温で一夜(18時間)撹拌した。その後、混合物
を飽和炭酸水素ナトリウム溶液200mlに注ぎ、水相
を分離し、ジエチルエーテル各300mlで2回逆抽出
した。有機相を飽和塩化ナトリウム溶液各250mlで
2回洗浄し、濃縮し、硫酸ナトリウム上で乾燥し、そし
て乾燥剤を濾別した。濾液を回転蒸発機(水浴温度40
℃)で濃縮した後、褐−黄色油として粗製の(1S,4
R,6R)−4−(2−メトキシ−2−プロピル)オキ
シ−1−[5−(2−メトキシ−2−プロピル)オキシ
−3−メチル−3E−ペンテン−1−イニル]−2,2,
6−トリメチルシクロヘキシルベンゾエートが得られ
る。
C) The solution obtained as described in section b) above is treated dropwise at -15 ° C. within 15 minutes with the solution prepared as described in section a) above and the mixture is treated. The mixture was stirred at room temperature for another hour. The mixture is cooled to -10 ° C and treated with 18.6 ml of benzoyl chloride with stirring,
It was then stirred overnight (18 hours) at room temperature. Then the mixture was poured into 200 ml of saturated sodium hydrogen carbonate solution, the aqueous phase was separated and back-extracted twice with 300 ml of diethyl ether each. The organic phase is washed twice with 250 ml each of saturated sodium chloride solution, concentrated, dried over sodium sulphate and the desiccant is filtered off. The filtrate was rotary evaporated (water bath temperature 40
C) and then crude (1S, 4
R, 6R) -4- (2-Methoxy-2-propyl) oxy-1- [5- (2-methoxy-2-propyl) oxy-3-methyl-3E-penten-1-ynyl] -2,2 ,
6-Trimethylcyclohexylbenzoate is obtained.

【0047】d)得られた褐−黄色油をテトラヒドロフ
ラン400ml及び水20mlに溶解し(濁つた溶
液)、ピリジニウムp−トシレート1gで処理し、更に
15分間撹拌した(透明な溶液)。次にこの混合物を飽
和炭酸水素ナトリウム溶液200mlに注ぎ、水相を分
離し、ジエチルエーテル各300mlで2回抽出した。
有機相を合液し、硫酸ナトリウム上で乾燥し、乾燥剤を
濾別した。濾液を回転蒸発機(浴温度40℃)で濃縮し
た後、粗製の生成物51.3gが得られ、このものをシ
リカゲル上でジエチルエーテル/ヘキサン(容量比2:
1)によつてクロマトグラフイーにかけた。生成物を含
むフラクシヨンから、淡黄色油として、純粋な(1S,
4R,6R)−4−ヒドロキシ−1−(5−ヒドロキシ
−3−メチル−3E−ペンテン−1−イニル)−2,2,
6−トリメチルシクロヘキシルベンゾエート合計32.
2g(86.1%)が得られた。
D) The brown-yellow oil obtained was dissolved in 400 ml of tetrahydrofuran and 20 ml of water (turbid solution), treated with 1 g of pyridinium p-tosylate and stirred for a further 15 minutes (clear solution). Then the mixture was poured into 200 ml of saturated sodium hydrogen carbonate solution, the aqueous phase was separated and extracted twice with 300 ml of diethyl ether each.
The organic phases were combined, dried over sodium sulphate and the desiccant was filtered off. After concentrating the filtrate on a rotary evaporator (bath temperature 40 ° C.), 51.3 g of crude product are obtained, which on silica gel is diethyl ether / hexane (volume ratio 2:
Chromatography according to 1). From the product-containing fraction, a pure yellow (1S,
4R, 6R) -4-Hydroxy-1- (5-hydroxy-3-methyl-3E-penten-1-ynyl) -2,2,
Total of 6-trimethylcyclohexyl benzoate 32.
2 g (86.1%) were obtained.

【0048】実施例5 撹拌機、温度計、滴下ロート、還流冷却器及び不活性ガ
ス化装置を備えたスルホン化用フラスコ中にtert.
ブタノール40ml及び無水トルエン50mlをアルゴ
ン下で入れ、そして−25℃に冷却した。この溶液を−
30℃〜20℃で30分以内に、ヘキサン中のブチルリ
チウムの1.56M溶液130mlで滴下処理し、この
混合物を冷却しながら更に30分間撹拌した。次いでか
くして製造したリチウムtert.ブチレートの溶液に
6℃で無水トルエン150ml中のエチル(1S,4R,
6R)−4−ヒドロキシ−1−(5−ヒドロキシ−3−
メチル−3E−ペンテン−1−イニル)−2,2,6−ト
リメチルシクロヘキシルカルボネート(実施例2に従つ
て製造したもの)32.4gの溶液を一度に加えた。こ
の混合物を油浴によつて注意して55℃に加熱し、この
温度で30分間撹拌した。その後、混合物を氷/水40
0mlに注いだ。水相を分離し、ジエチルエーテル各3
00mlで2回抽出した。有機相を飽和塩化ナトリウム
溶液300mlで洗浄し、合液し、硫酸ナトリウム上で
乾燥し、約40℃にて回転蒸発機で濃縮し、次に残渣を
高真空下にて室温で5時間乾燥した。かくして(4R)
−5−(4−ヒドロキシ−2,6,6−トリメチル−1−
シクロヘキセニル)−3−メチル−2−ペンテン−4−
イン−1−オール(2Z異性体1.4%と共に2E異性
体90.5%含有)の黄−橙色の結晶性生成物23.9g
(102.1%)が得られ、このものをシリカゲル上で
ジエチルエーテル/ヘキサン(容量比1:1)によつて
クロマトグラフイーにかけた。生成物を含むフラクシヨ
ンから、帯黄色の結晶として(4R)−5−(4−ヒド
ロキシ−2,6,6−トリメチル−1−シクロヘキセン−
1−イル)−3−メチル−2E−ペンテン−4−イン−
1−オール(純度98.0%、2Z異性体含量0.5%)
合計19.9g(85%)が得られた。
Example 5 In a sulfonation flask equipped with a stirrer, a thermometer, a dropping funnel, a reflux condenser and an inert gasifier, tert.
40 ml butanol and 50 ml anhydrous toluene were charged under argon and cooled to -25 ° C. This solution-
Within 30 minutes at 30 ° C. to 20 ° C., 130 ml of a 1.56 M solution of butyllithium in hexane were added dropwise and the mixture was stirred for a further 30 minutes while cooling. The lithium tert. To a solution of butyrate at 6 ° C in ethyl acetate (1S, 4R,
6R) -4-hydroxy-1- (5-hydroxy-3-
A solution of 32.4 g of methyl-3E-penten-1-ynyl) -2,2,6-trimethylcyclohexyl carbonate (prepared according to Example 2) was added in one portion. The mixture was carefully heated to 55 ° C. with an oil bath and stirred at this temperature for 30 minutes. Then mix the mixture with ice / water 40
Poured to 0 ml. Separate the aqueous phase and use 3 portions of diethyl ether.
It was extracted twice with 00 ml. The organic phase is washed with 300 ml of saturated sodium chloride solution, combined, dried over sodium sulphate and concentrated on a rotary evaporator at about 40 ° C., then the residue is dried under high vacuum at room temperature for 5 hours. . Thus (4R)
-5- (4-hydroxy-2,6,6-trimethyl-1-
Cyclohexenyl) -3-methyl-2-pentene-4-
23.9 g of a yellow-orange crystalline product of in-1-ol (containing 1.4% of 2Z isomer and 90.5% of 2E isomer).
(102.1%) was obtained, which was chromatographed on silica gel with diethyl ether / hexane (volume ratio 1: 1). From the product-containing fraction, (4R) -5- (4-hydroxy-2,6,6-trimethyl-1-cyclohexene-) was obtained as yellowish crystals.
1-yl) -3-methyl-2E-penten-4-yn-
1-ol (purity 98.0%, 2Z isomer content 0.5%)
A total of 19.9 g (85%) was obtained.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 エーリツヒ・ビドマー スイス国4142ミユンヘンシユタイン・ミツ テルベーク47 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Erich Widmer Switzerland 4142 Miyun Hengsyu Tyne Mitsu Terbeek 47

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 一般式 【化1】 式中、 R2は水素またはヒドロキシを表わし、 R3はヒドロキシまたは=CH−CH2−OHを表わし、 R4は−CO−OR6′または−CO−R6″を表わし、 R6′はアルキルを表わし、そしてR6″はアリールまた
はアルキルアリールを表わす、で示される化合物。
1. A general formula: In the formula, R 2 represents hydrogen or hydroxy, R 3 represents hydroxy or ═CH—CH 2 —OH, R 4 represents —CO—OR 6 ′ or —CO—R 6 ″, and R 6 ′ represents A compound of the formula: alkyl, and R 6 ″ represents aryl or alkylaryl.
JP4150084A 1983-06-09 1992-05-19 Cycloalkyl alkynes Expired - Lifetime JPH0610148B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH3153/83-0 1983-06-09
CH315383 1983-06-09
CH558383 1983-10-13
CH5583/83-2 1983-10-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP59115609A Division JPS608238A (en) 1983-06-09 1984-06-07 Manufacture of cycloalkenyl alkines

Publications (2)

Publication Number Publication Date
JPH05194292A JPH05194292A (en) 1993-08-03
JPH0610148B2 true JPH0610148B2 (en) 1994-02-09

Family

ID=25692324

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4150084A Expired - Lifetime JPH0610148B2 (en) 1983-06-09 1992-05-19 Cycloalkyl alkynes

Country Status (5)

Country Link
US (1) US4661641A (en)
EP (1) EP0131130B1 (en)
JP (1) JPH0610148B2 (en)
DE (1) DE3468208D1 (en)
DK (1) DK274884A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723480A1 (en) * 1997-06-04 1998-12-10 Basf Ag Process for the preparation of zeaxanthin, intermediates for this process and process for its preparation
CA2647900C (en) * 2008-12-23 2017-05-16 National Research Council Of Canada Inhibitors of a 9-cis-epoxycarotenoid dioxygenase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2931828A (en) * 1955-11-24 1960-04-05 Belge Des Lab Labaz Soc Carbamate of propinyl, cyclohexanol
US2993864A (en) * 1956-08-02 1961-07-25 Dow Chemical Co Ethynylcyclohexyl compounds as corrosion inhibitors
DE2558806C2 (en) * 1975-12-27 1984-08-02 Basf Ag, 6700 Ludwigshafen Substituted 1-alkenynyl-cyclohexanols and processes for their preparation and their use in the preparation of β-damascones
US4219506A (en) * 1979-01-17 1980-08-26 Hoffmann-La Roche Inc. Process for producing vitamin A
US4336401A (en) * 1980-07-17 1982-06-22 Hercules Incorporated Process for the preparation of damascenone

Also Published As

Publication number Publication date
EP0131130A1 (en) 1985-01-16
DE3468208D1 (en) 1988-02-04
US4661641A (en) 1987-04-28
DK274884A (en) 1984-12-10
JPH05194292A (en) 1993-08-03
DK274884D0 (en) 1984-06-01
EP0131130B1 (en) 1987-12-23

Similar Documents

Publication Publication Date Title
JP2542667B2 (en) Ethynylcyclohexene derivative
US5227507A (en) Ethynylcyclohexene compounds and processes for manufacture thereof
WO2004000826A1 (en) Processes for producing epoxytriazole derivative and intermediate therefor
US4950767A (en) Process for the preparation of the (-)-antipode of (E)-1-cyclohexyl-4,4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ene
EP1756027B1 (en) Process for producing indenol esters or ethers
JPH0610148B2 (en) Cycloalkyl alkynes
JP2008546818A (en) Process for producing 1- [cyano (4-hydroxyphenyl) methyl] cyclohexanol compound
JPH0472812B2 (en)
EP0688752B1 (en) Trifluoro-2-(trans-4-substituted cyclohexyl) ethylenes and process for their production
JP4563997B2 (en) Method for preparing 9-cis retinoic acid
JP4176201B2 (en) Method for producing 5-halogeno-2-substituted pyridine
HU218699B (en) Process for the preparation of pesticidal fluorine olefines and of intermediates thereof and the intermediates
JPH0466216B2 (en)
JPH11116552A (en) Production of zeaxanthin and intermediate therefor, and its production
JP2000095730A (en) Production of halogenated phenylmalonic ester
JPH0456029B2 (en)
JP3855686B2 (en) 3,3-dialkoxy-2-hydroxyimino derivative and process for producing the same
JP4541143B2 (en) Method for producing quinoline derivative
JPH0623176B2 (en) Process for producing asymmetric dithioacetal and dithioketal
US6096894A (en) Production method of 2-(p-alkylphenyl)pyridine compound
JP3926416B2 (en) Method for producing trimethylsulfoxonium bromide
JP2007507517A (en) Method for producing 1- [cyano (phenyl) methyl] cyclohexanol compound
BE856317Q (en) PROCESS FOR PREPARING ARYLALCANOIC ACIDS
JPH0147464B2 (en)
JP3965704B2 (en) Process for producing optically active 5-hydroxy-3-oxo-6-heptynoic acid ester derivative